Dermorphin Peptide Acetate

Dermorphin Peptide Acetate|High-Affinity μ-Opioid Receptor Agonist D-Amino Acid-Stabilized Heptapeptide API rau Mob Mechanism Research & Opioid Pharmacology GMP Chaw tsim tshuaj paus Tuam Tshoj bulk Supply

Cov khoom tseem ceeb:

• Siab -kev sib raug zoo thiab xaiv μ-opioid receptor agonist
• D-amino acid-stabilized heptapeptide nrog txhim kho enzymatic tsis kam
• Ntev ntev receptor activation nyob rau hauv kev sim pharmacology systems
• Ua tau zoo ntshav-hlwb barrier penetration muaj peev xwm
• Tsawg-endotoxin GMP- qib batch sib xws
• Haum rau opioid receptor thiab mob mechanism tshawb fawb qauv

Dermorphin Peptide Acetateyog ib qho hluavtaws heptapeptide muab los ntawm amphibian daim tawv nqaij peptides thiab ua kom zoo dua los ntawm cov khoom siv -theem peptide synthesis (SPPS). Nws muaj ib qho D-alanine residue uas ua rau muaj txiaj ntsig zoo rau kev sib txuas ntawm receptor affinity thiab enzymatic stability piv nrog cov pa endogenous opioid peptides.

Nws ua haujlwm raws li kev xaiv μ-opioid receptor agonist, ua kom muaj kev hloov pauv ntawm nociceptive teeb liab kis tau tus mob nyob rau hauv nruab nrab thiab peripheral paj hlwb. Nws yog dav siv hauv opioid receptor pharmacology thiab kev tshawb fawb txog kev mob.

• Kev xaiv siab rau μ-opioid receptor nrog tsawg δ- receptor cuam tshuam
• D-amino acid kev koom ua ke txhim kho kev ruaj ntseg ntawm proteolytic
• Txhim kho ntshav-hlwb barrier permeability
• Solubility zoo nyob rau hauv dej, PBS, thiab cell kab lis kev cai xov xwm
• Tsawg endotoxin profile txo qhov tsis yog -kev cuam tshuam tshwj xeeb
• Haum rau ob qho tib si hauv vitro thiab hauv vivo kev tshawb fawb tshuaj

• Ua kom μ-opioid receptor-mediated Gi/o protein qhia txoj hauv kev
• Inhibits adenylyl cyclase kev ua haujlwm thiab txo cov qib cAMP hauv lub cev
• Modulates voltage-gated calcium thiab potassium channel kev ua si
• Supresses ascending nociceptive teeb liab kis tau tus mob
• Induces sustained analgesic teebmeem hauv kev sim ua qauv
• Regulates neuronal excitability nyob rau hauv central thiab peripheral systems

• Fmoc solid{0}}phase peptide synthesis (SPPS) platform
• Kev sib xyaw ua ke ntawm D-amino acid residue
• High structural fidelity nrog qis los ntawm - khoom tsim
• Yam tsawg kawg nkaus yuav tsum tau ua kom huv huv theem nrab
• Muaj zog batch-rau-batch reproducibility nyob rau hauv GMP system
• GMP kev tsim khoom hauv Suav teb rau cov khoom siv thoob ntiaj teb

Dermorphin Peptide Acetateexerts nws cov tshuaj pharmacological los ntawm kev xaiv qhib ntawm μ-opioid receptors nyob rau hauv nruab nrab thiab peripheral paj hlwb.

Lub D-alanine residue muaj zog tiv thaiv kev degradation enzymatic, ua kom ntev peptide stability nyob rau hauv ib puag ncig lom.

Mechanistically, nws:

• Ua kom μ-opioid receptor-mediated Gi/o protein signaling
• inhibits adenylyl cyclase, txo cov qib cAMP intracellular
• Modulates calcium influx thiab potassium efflux los ntawm ion raws
• Txhawb nqa nociceptive teeb liab kis tau tus mob nyob rau hauv tus txha caj qaum thiab supraspinal txoj kev
• Minimizes tawm -lub hom phiaj receptor activation, txhim kho kev sim tshwj xeeb

• GMP-qib huv chav tsim khoom ib puag ncig
• Pharmaceutical -qib amino acid raw khoom
• Multi-theem synthesis, purification, thiab sterile lyophilization
• Tag nrho batch tso tawm kev sim ua ntej xa zaub mov
• 2-xyoo khaws cov qauv traceability system
• Ua kom tiav cov ntaub ntawv xa tawm (COA / MSDS / tsis yog{0}} daim ntawv pov thawj txaus ntshai)

Q: Dab tsi txawv Dermorphin los ntawm cov pa opioid peptides?
Nws muaj D-amino acid residue, uas txhim kho kev ruaj ntseg ntawm cov enzymes, receptor affinity, thiab lom ib nrab-lub neej.

Q: dermorphin peptide ua dab tsi?

A: Nws ua raws li kev xaiv ntau μ-opioid receptor agonist rau kev tshawb fawb txog kev kho mob ntawm cov teeb liab kev cai, opioid receptor pharmacology thiab kev tshawb fawb txog paj hlwb.

Q: Puas yog dermorphin ntxiv?

A: Nws muaj cov yam ntxwv zoo uas muaj peev xwm ua rau muaj kev pheej hmoo cuam tshuam nrog μ- qhib opioid, yog li nws tsuas yog yuav tsum tau siv rau hauv cov chaw soj ntsuam nruj me ntsis.

Q: Puas yog dermorphin pom zoo los ntawm FDA?

A: Nws tsis tau txais kev pom zoo los ntawm FDA rau tib neeg kev siv tshuaj kho mob, thiab tsuas yog npaj rau kev tshawb fawb hauv chaw kuaj mob.

Cim npe nrov: Tuam Tshoj dermorphin peptide acetate manufacturers, lwm tus neeg, Hoobkas